论文部分内容阅读
简要叙述了C-erbB-2癌基因的特点与生物学功能。在此基础上阐述了C-erbB-2癌基因在NSCLC中的表达程度与临床分期及预后的关系,并总结了近年来基于C-erbB-2癌基因治疗非小细胞肺癌(NSCLC)的进展及取得的成就。
Briefly describe the features and biological functions of C-erbB-2 oncogene. Based on this, the relationship between the expression of C-erbB-2 oncogene and clinical stage and prognosis in NSCLC was expounded. The progress of non-small cell lung cancer (NSCLC) based on C-erbB-2 oncogene in recent years was summarized And the achievements made.